Sanara MedTech Statistics

Total Valuation

Sanara MedTech has a market cap or net worth of $171.38 million. The enterprise value is $202.99 million.

Market Cap	171.38M
Enterprise Value	202.99M

Important Dates

The next confirmed earnings date is Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Sanara MedTech has 9.16 million shares outstanding. The number of shares has increased by 1.64% in one year.

Current Share Class	9.16M
Shares Outstanding	9.16M
Shares Change (YoY)	+1.64%
Shares Change (QoQ)	-5.23%
Owned by Insiders (%)	20.52%
Owned by Institutions (%)	18.97%
Float	4.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	162.61
PS Ratio	1.66
Forward PS	1.43
PB Ratio	28.17
P/TBV Ratio	n/a
P/FCF Ratio	79.31
P/OCF Ratio	25.25
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.19, with an EV/FCF ratio of 93.94.

EV / Earnings	n/a
EV / Sales	1.97
EV / EBITDA	17.19
EV / EBIT	22.20
EV / FCF	93.94

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 8.13.

Current Ratio	1.80
Quick Ratio	1.53
Debt / Equity	8.13
Debt / EBITDA	3.90
Debt / FCF	22.30
Interest Coverage	1.35

Financial Efficiency

Return on equity (ROE) is -1.75% and return on invested capital (ROIC) is 9.12%.

Return on Equity (ROE)	-1.75%
Return on Assets (ROA)	7.10%
Return on Invested Capital (ROIC)	9.12%
Return on Capital Employed (ROCE)	16.84%
Weighted Average Cost of Capital (WACC)	10.48%
Revenue Per Employee	$954,796
Profits Per Employee	-$347,802
Employee Count	108
Asset Turnover	1.28
Inventory Turnover	2.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.05% in the last 52 weeks. The beta is 1.10, so Sanara MedTech's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-41.05%
50-Day Moving Average	18.97
200-Day Moving Average	24.77
Relative Strength Index (RSI)	48.68
Average Volume (20 Days)	40,424

Short Selling Information

The latest short interest is 261,073, so 2.85% of the outstanding shares have been sold short.

Short Interest	261,073
Short Previous Month	249,624
Short % of Shares Out	2.85%
Short % of Float	5.51%
Short Ratio (days to cover)	3.79

Income Statement

In the last 12 months, Sanara MedTech had revenue of $103.12 million and -$37.56 million in losses. Loss per share was -$4.36.

Revenue	103.12M
Gross Profit	95.60M
Operating Income	9.15M
Pretax Income	-393,124
Net Income	-37.56M
EBITDA	11.81M
EBIT	9.15M
Loss Per Share	-$4.36

Full Income Statement

Balance Sheet

The company has $16.58 million in cash and $48.19 million in debt, giving a net cash position of -$31.61 million or -$3.45 per share.

Cash & Cash Equivalents	16.58M
Total Debt	48.19M
Net Cash	-31.61M
Net Cash Per Share	-$3.45
Equity (Book Value)	5.93M
Book Value Per Share	0.66
Working Capital	14.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $6.79 million and capital expenditures -$4.63 million, giving a free cash flow of $2.16 million.

Operating Cash Flow	6.79M
Capital Expenditures	-4.63M
Depreciation & Amortization	2.66M
Net Borrowing	12.25M
Free Cash Flow	2.16M
FCF Per Share	$0.24

Full Cash Flow Statement

Margins

Gross margin is 92.71%, with operating and profit margins of 8.87% and -36.43%.

Gross Margin	92.71%
Operating Margin	8.87%
Pretax Margin	-0.38%
Profit Margin	-36.43%
EBITDA Margin	11.45%
EBIT Margin	8.87%
FCF Margin	2.10%

Dividends & Yields

Sanara MedTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.64%
Shareholder Yield	-1.64%
Earnings Yield	-21.92%
FCF Yield	1.26%

Analyst Forecast

The average price target for Sanara MedTech is $34.00, which is 81.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.00
Price Target Difference	81.82%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:100.

Last Split Date	May 10, 2019
Split Type	Reverse
Split Ratio	1:100

Scores

Sanara MedTech has an Altman Z-Score of 3 and a Piotroski F-Score of 5.

Altman Z-Score	3
Piotroski F-Score	5